Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04341064 · ClinicalTrials.gov registry record · Phase 3
Sun-safe Habits Intervention and Education
A Phase 3 study of Skin Cancer and Adolescents, sponsored by University of Utah.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,223
- Enrollment target
- 1
- Study location
NCT04341064: Completed Phase 3 study of Skin Cancer and Adolescents, sponsored by University of Utah.
NCT04341064 is a Phase 3 study of Skin Cancer and Adolescents that has completed, run by University of Utah. The registered enrollment target is 2,223 participants, above the 409-participant average among 40 other Skin Cancer trials with a reported enrollment target (444% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04341064, a Phase 3 study of Skin Cancer and Adolescents, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,223 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the efficacy of the Sun-safe Habits Intervention and Education (SHINE) intervention in improving sun protection use and decreasing intentional tanning among high school students. It's anticipated that 30 schools will be randomized into the trial, with approximately half assigned to SHINE and the other half assigned to standard education. After randomization and a baseline assessment, each school will receive two in-class intervention sessions delivered by an interventionist. Follow-up assessments will be completed one month post-intervention, 3-4 months post-intervention, one year post-baseline, and one year post-intervention.
Primary Outcome
Mean/standard deviation of the difference in sunscreen application occurrence between timepoints. "These next questions ask about what you have typically done in the past month when you were outdoors in the sun for 1 hour or more. How often did you wear sunscreen?" Minimum value = 1; Maximum value = 5; Higher scores indicate a better outcome
Conditions Studied
Interventions
- BEHAVIORAL SHINE Intervention
Study Locations (1)
Utah
- Huntsman Cancer Institute - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,223 participants |
| Start Date | 2020-09-14 |
| Est. Completion | 2025-07-15 |
| Phase | Phase 3 |
What the finished NCT04341064 record still lists
NCT04341064 is an interventional study that assigns participants to a tested intervention. Its 2,223 participants enrollment target places it among the larger protocols in the corpus, above the 409-participant average among 40 other Skin Cancer trials with a reported enrollment target (444% higher).
The record links to 2 conditions, with Skin Cancer appearing as the primary indexed condition, and to 1 intervention - of which SHINE Intervention is the first listed.
NCT04341064 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT04341064 about?
NCT04341064 is a clinical study titled "Sun-safe Habits Intervention and Education". The purpose of this study is to determine the efficacy of the Sun-safe Habits Intervention and Education (SHINE) intervention in improving sun protection use and decreasing intentional tanning among high school students. It's anticipated that 30 schools will be randomized into the trial, with approx...
What is the current status of trial NCT04341064?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,223 participants. The study started on 2020-09-14. Estimated completion is 2025-07-15.
What conditions does trial NCT04341064 study?
This clinical trial studies the following conditions: Skin Cancer, Adolescents.
What interventions are being tested in trial NCT04341064?
The interventions under investigation include: SHINE Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04341064?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04341064 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04341064's enrollment target sits among peer trials
2,223 3rd of 40 higher than 38 of 40 other Skin Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Skin Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Undergraduate Skin Cancer Prevention Trial
RECRUITING · Phase 3
-
Rural Adult and Youth Sun Protection Study
RECRUITING · NA
-
TIL Therapy in cSCC and MCC
RECRUITING · Phase 2
-
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
RECRUITING
-
Meloxicam in Mohs Micrographic Surgery
RECRUITING · Phase 4
-
Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06831929 · 2,232 participants · NA
HPV Ends Here: Increasing Uptake of the HPV Vaccine
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06144554 · 2,200 participants
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI